Published in Gene Therapy Weekly, April 6th, 1998
The report from the University of North Carolina in Chapel Hill (UNC-CH) was based on a study of more than 600 black and white women, with and without breast cancer. The researchers said they found a low prevalence of the mutation - called BRCA1 - in women in general.
"Testing women from the general population for the entire (mutation) sequences is of questionable value, because a large number of women would be tested, expensively, to detect few mutations, and the negative...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.